Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Single-Blind	STARTED	Valsartan/Amlodipine 80/5 mg	0
Single-Blind	STARTED	Valsartan 80 mg	1,134
Single-Blind	STARTED	Valsartan 160 mg	0
Single-Blind	COMPLETED	Valsartan/Amlodipine 80/5 mg	0
Single-Blind	COMPLETED	Valsartan 80 mg	918
Single-Blind	COMPLETED	Valsartan 160 mg	0
Single-Blind	NOT COMPLETED	Valsartan/Amlodipine 80/5 mg	0
Single-Blind	NOT COMPLETED	Valsartan 80 mg	216
Single-Blind	NOT COMPLETED	Valsartan 160 mg	0
Double-Blind	STARTED	Valsartan/Amlodipine 80/5 mg	308
Double-Blind	STARTED	Valsartan 80 mg	307
Double-Blind	STARTED	Valsartan 160 mg	303
Double-Blind	COMPLETED	Valsartan/Amlodipine 80/5 mg	293
Double-Blind	COMPLETED	Valsartan 80 mg	293
Double-Blind	COMPLETED	Valsartan 160 mg	285
Double-Blind	NOT COMPLETED	Valsartan/Amlodipine 80/5 mg	15
Double-Blind	NOT COMPLETED	Valsartan 80 mg	14
Double-Blind	NOT COMPLETED	Valsartan 160 mg	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00413413/flow